MX2022016174A - Composiciones y metodos para tratar un trastorno obsesivo-compulsivo. - Google Patents

Composiciones y metodos para tratar un trastorno obsesivo-compulsivo.

Info

Publication number
MX2022016174A
MX2022016174A MX2022016174A MX2022016174A MX2022016174A MX 2022016174 A MX2022016174 A MX 2022016174A MX 2022016174 A MX2022016174 A MX 2022016174A MX 2022016174 A MX2022016174 A MX 2022016174A MX 2022016174 A MX2022016174 A MX 2022016174A
Authority
MX
Mexico
Prior art keywords
compulsive disorder
compositions
methods
treating obsessive
obsessive
Prior art date
Application number
MX2022016174A
Other languages
English (en)
Spanish (es)
Inventor
Vladimir Coric
Robert Berman
Loren Aguiar
Original Assignee
Biohaven Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohaven Therapeutics Ltd filed Critical Biohaven Therapeutics Ltd
Publication of MX2022016174A publication Critical patent/MX2022016174A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2022016174A 2020-06-24 2021-06-24 Composiciones y metodos para tratar un trastorno obsesivo-compulsivo. MX2022016174A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063043681P 2020-06-24 2020-06-24
PCT/US2021/038789 WO2021262914A1 (en) 2020-06-24 2021-06-24 Compositions and methods for treating obsessive-compulsive disorder

Publications (1)

Publication Number Publication Date
MX2022016174A true MX2022016174A (es) 2023-01-24

Family

ID=79281806

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022016174A MX2022016174A (es) 2020-06-24 2021-06-24 Composiciones y metodos para tratar un trastorno obsesivo-compulsivo.

Country Status (12)

Country Link
US (1) US20230181541A1 (https=)
EP (1) EP4171554A4 (https=)
JP (1) JP7805969B2 (https=)
KR (1) KR20230027189A (https=)
CN (1) CN115968312A (https=)
AU (1) AU2021297249A1 (https=)
BR (1) BR112022025901A2 (https=)
CA (1) CA3187323A1 (https=)
IL (1) IL299301A (https=)
MX (1) MX2022016174A (https=)
PH (1) PH12022553441A1 (https=)
WO (1) WO2021262914A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP2400349A1 (hu) * 2024-07-05 2026-01-28 Egis Gyógyszergyár Zrt. Troriluzole-hidroklorid-sók

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2564187T3 (es) * 2005-04-05 2016-03-18 Yale University Agentes de modulación de glutamato en el tratamiento de trastornos mentales
WO2016140879A1 (en) * 2015-03-03 2016-09-09 Biohaven Pharmaceutical Holding Company Ltd. Riluzole prodrugs and their use
JP2018521007A (ja) * 2015-05-22 2018-08-02 ヴィスタゲン セラピューティクス、インコーポレイテッド Ｌ−４−クロロキヌレニンの治療的使用
TW202000205A (zh) * 2018-02-21 2020-01-01 美商Ａｉ治療公司 使用阿吡莫德與麩胺酸性劑的組合治療
MX2020012377A (es) * 2018-05-27 2021-04-12 Biohaven Therapeutics Ltd Uso de tabletas de desintegracion orales de riluzol para el tratamiento de enfermedades.
MX2021000515A (es) * 2018-07-22 2021-06-08 Biohaven Therapeutics Ltd Uso de profarmacos de riluzol para tratar enfermedad de alzheimer.
US20210315865A1 (en) * 2018-08-16 2021-10-14 Biohaven Therapeutics Ltd. Use of riluzole oral disintigrating tablets for treating diseases

Also Published As

Publication number Publication date
AU2021297249A1 (en) 2023-02-23
BR112022025901A2 (pt) 2023-01-10
WO2021262914A1 (en) 2021-12-30
IL299301A (en) 2023-02-01
EP4171554A1 (en) 2023-05-03
US20230181541A1 (en) 2023-06-15
PH12022553441A1 (en) 2024-03-04
CA3187323A1 (en) 2021-12-30
CN115968312A (zh) 2023-04-14
KR20230027189A (ko) 2023-02-27
JP2023531919A (ja) 2023-07-26
JP7805969B2 (ja) 2026-01-26
EP4171554A4 (en) 2024-07-31

Similar Documents

Publication Publication Date Title
ZA202109010B (en) Compounds and methods for the treatment of covid-19
MX2011007854A (es) Metodos para tratar infartos agudos al miocardio y trastornos relacionados.
NZ630367A (en) Methods of treatment of pediatric solid tumor
MX2024014121A (es) Metodos y composiciones para el tratamiento del exceso de glucocorticoides
AU2018282105A1 (en) Dosing of vibegron for treatment of overactive bladder
WO2022010813A3 (en) Enhancing immune responses through targeted antigen expression
MX2020007817A (es) Prevención y tratamiento del trastorno del sueño.
PH12022553441A1 (en) Compositions and methods for treating obsessive-compulsive disorder
MX2023001233A (es) Metodos de tratamiento del cancer positivo para her2 con tucatinib en combinacion con trastuzumab, un taxano y un antagonista del vegfr-2.
EA202290027A1 (ru) Способы и композиции для улучшения результатов лечения пациентов с раком
MX2022004785A (es) Metodos y composiciones para el tratamiento del sindrome de rett.
MX2023006704A (es) Composiciones dsg2 y metodos para el tratamiento de covid-19.
MX2020007222A (es) Metodos para el tratamiento de afecciones inflamatorias de la piel.
MX2023003723A (es) Anticuerpos anti-il-36r para el tratamiento de dolor inflamatorio cronico.
MY200247A (en) Methods and compositions for inhibition of egf/egfr pathway in combination with tyrosine kinase inhibitors
MX2025000682A (es) Composicion farmaceutica de anticuerpo anti-cd20 y uso de la misma
EP4467131A3 (en) Microbiota restoration therapy (mrt) compositions and methods of manufacture
MX2023009620A (es) Metodos terapeuticos.
CR20230190A (es) Compuesto degradante en un medicamento
MX2023008796A (es) Métodos para el tratamiento del trastorno del habla en niños.
MX2023000151A (es) Terapia de combinacion de verapamilo y mometasona para el tratamiento de rinosinusitis cronica.
ZA202202673B (en) Methods and compositions for treating endometriosis
MX2024002602A (es) Métodos para prevenir y tratar el dolor y síntomas asociados.
MX2025006987A (es) Metodos para aumentar el bienestar mental y/o la felicidad
ATE501724T1 (de) Lektinzusammensetzung zur prophylaxe und/oder behandlung von unerwünschten arzneimittelnebenwirkungen